| 1 | Autologous mature tolerogenic monocyte-derived Dendritic Cells loaded with the B29 peptide of HSP70 | - | - | - | - | [1] 46 46 💬
|
| 2 | Autologous VitD3 tolerogenic monocyte-derived dendritic cells loaded with a pool of myelin peptides (tolDC-VitD3) | [1] Myelin basic protein Myelin basic protein | - | - | - | [1] 13 13 💬
|
| 3 | Cotoretigene Toliparvovec | [1] Cotoretigene toliparvovec Cotoretigene toliparvovec (Cotoretigene toliparvovec) | - | - | - | [1] 90 90 💬
|
| 4 | Itraconazole (TOLSURA) | [1] Itraconazole Itraconazole (Tolsura) | [1] Itraconazole
Itraconazole
(TOLSURA) 💬
| - | - | [6] 3 3, 46, 65, 96, 227, 299 💬
|
| 5 | Itraconazole 400 mg/day and terbinafine 500 mg/day administered orally. (TOLSURA) | [2] Itraconazole Itraconazole (Tolsura), Terbinafine (Terbinafine HCl Chlortimazole and Tolnaftate) | [2] Itraconazole
Itraconazole
(TOLSURA),
Terbinafine
💬
| - | - | [1] 96 96 💬
|
| 6 | Itraconazole/voriconazole (TOLSURA) | [2] Itraconazole Itraconazole (Tolsura), Voriconazole | [2] Itraconazole
Itraconazole
(TOLSURA),
Voriconazole
💬
| - | - | [1] 299 299 💬
|
| 7 | Itraconazole? SHR0302 tablets (TOLSURA) | [1] Itraconazole Itraconazole (Tolsura) | [1] Itraconazole
Itraconazole
(TOLSURA) 💬
| - | - | [1] 46 46 💬
|
| 8 | Jinarc - Tolvaptan tablets | [1] Tolvaptan Tolvaptan (Tolvaptan) | [1] Tolvaptan
Tolvaptan
(Tolvaptan) 💬
| [1] AVPR2 AVPR2 💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [1] 67 67 💬
|
| 9 | Modified Oral Glucose Tolerance Test (50g 4-hours) | [1] Dextrose, unspecified form Dextrose, unspecified form (50gm Glucose Tolerance Drink) | - | - | - | [1] 299 299 💬
|
| 10 | OPC-41061 (tolvaptan) | [1] Tolvaptan Tolvaptan (Tolvaptan) | [1] Tolvaptan
Tolvaptan
(Tolvaptan) 💬
| [1] AVPR2 AVPR2 💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [1] 67 67 💬
|
| 11 | Oral Glucose Tolerance test (75g 2-hour) | [1] Dextrose, unspecified form Dextrose, unspecified form (50gm Glucose Tolerance Drink) | - | - | - | [1] 299 299 💬
|
| 12 | Oxybutynin, tolterodine, solifenacin | [3] Oxybutynin Oxybutynin, Solifenacin, Tolterodine (Tolterodine Tartarate) | [3] Oxybutynin
Oxybutynin
,
Tolterodine
(Tolterodine),
Solifenacin
💬
| [5] CHRM1 CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬
| [13] Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | [1] 53 53 💬
|
| 13 | TOL | - | - | - | - | [1] 67 67 💬
|
| 14 | Tolcapon | [1] Tolcapone Tolcapone (Tolcapon) | [1] Tolcapone
Tolcapone
(Tolcapone) 💬
| [1] COMT COMT 💬
| [4] Dopaminergic synapse Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬 | [1] 6 6 💬
|
| 15 | TOLCAPONE | [1] Tolcapone Tolcapone (Tolcapon) | [1] Tolcapone
Tolcapone
(Tolcapone) 💬
| [1] COMT COMT 💬
| [4] Dopaminergic synapse Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬 | [3] 6 6, 28, 127 💬
|
| 16 | TolDC | - | - | - | - | [1] 46 46 💬
|
| 17 | Tolebrutinib | - | - | - | - | [2] 11 11, 13 💬
|
| 18 | Tolebrutinib 120mg | - | - | - | - | [1] 13 13 💬
|
| 19 | Tolebrutinib 60mg | - | - | - | - | [1] 13 13 💬
|
| 20 | Tolebrutininb | - | - | - | - | [1] 11 11 💬
|
| 21 | Tolerogenic dendritic cells | - | - | - | - | [2] 46 46, 96 💬
|
| 22 | Tolerogenic dendritic cells (tolDC) | - | - | - | - | [1] 13 13 💬
|
| 23 | Tolerogenic Dendritic cells loaded with myelin peptides | [1] Myelin basic protein Myelin basic protein | - | - | - | [1] 13 13 💬
|
| 24 | Tolerogenic Fibroblasts | - | - | - | - | [1] 13 13 💬
|
| 25 | Tolfenamic Acid | [1] Tolfenamic acid Tolfenamic acid (Tolfenamic acid) | [1] Tolfenamic acid
Tolfenamic acid
(Tolfenamic acid) 💬
| [2] PTGS1 PTGS1, PTGS2 💬
| [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 5 5 💬
|
| 26 | Tolicizumab | - | - | - | - | [1] 46 46 💬
|
| 27 | Tolicizumab Roche | - | - | - | - | [1] 46 46 💬
|
| 28 | Tolperisone | [1] Tolperisone Tolperisone (Tolperisone) | [1] Tolperisone
Tolperisone
(Tolperisone) 💬
| - | - | [1] 13 13 💬
|
| 29 | Tolperisone HC1 | [1] Tolperisone Tolperisone (Tolperisone) | [1] Tolperisone
Tolperisone
(Tolperisone) 💬
| - | - | [1] 13 13 💬
|
| 30 | Tolperisone HCl | [1] Tolperisone Tolperisone (Tolperisone) | [1] Tolperisone
Tolperisone
(Tolperisone) 💬
| - | - | [1] 13 13 💬
|
| 31 | Tolpersan | - | - | - | - | [1] 13 13 💬
|
| 32 | Tolposan | - | - | - | - | [1] 13 13 💬
|
| 33 | Tolterodine | [1] Tolterodine Tolterodine (Tolterodine Tartarate) | [1] Tolterodine
Tolterodine
(Tolterodine) 💬
| [1] CHRM3 CHRM3 💬
| [11] Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 💬 | [2] 17 17, 53 💬
|
| 34 | Tolubuterol Hydrochloride | - | - | - | - | [1] 6 6 💬
|
| 35 | TOLVAPTAN | [1] Tolvaptan Tolvaptan (Tolvaptan) | [1] Tolvaptan
Tolvaptan
(Tolvaptan) 💬
| [1] AVPR2 AVPR2 💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [4] 67 67, 72, 86, 225 💬
|
| 36 | TOLVAPTAN (OPC-41061) | [1] Tolvaptan Tolvaptan (Tolvaptan) | [1] Tolvaptan
Tolvaptan
(Tolvaptan) 💬
| [1] AVPR2 AVPR2 💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [1] 67 67 💬
|
| 37 | Tolvaptan (SAMSCA) | [1] Tolvaptan Tolvaptan (Tolvaptan) | [1] Tolvaptan
Tolvaptan
(Tolvaptan) 💬
| [1] AVPR2 AVPR2 💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [1] 72 72 💬
|
| 38 | TOLVAPTAN 15 | [1] Tolvaptan Tolvaptan (Tolvaptan) | [1] Tolvaptan
Tolvaptan
(Tolvaptan) 💬
| [1] AVPR2 AVPR2 💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [1] 67 67 💬
|
| 39 | Tolvaptan 15 mg Tablet | [1] Tolvaptan Tolvaptan (Tolvaptan) | [1] Tolvaptan
Tolvaptan
(Tolvaptan) 💬
| [1] AVPR2 AVPR2 💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [1] 67 67 💬
|
| 40 | Tolvaptan 15 mg tablets | [1] Tolvaptan Tolvaptan (Tolvaptan) | [1] Tolvaptan
Tolvaptan
(Tolvaptan) 💬
| [1] AVPR2 AVPR2 💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [1] 67 67 💬
|
| 41 | Tolvaptan 15mg | [1] Tolvaptan Tolvaptan (Tolvaptan) | [1] Tolvaptan
Tolvaptan
(Tolvaptan) 💬
| [1] AVPR2 AVPR2 💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [1] 67 67 💬
|
| 42 | TOLVAPTAN 30 | [1] Tolvaptan Tolvaptan (Tolvaptan) | [1] Tolvaptan
Tolvaptan
(Tolvaptan) 💬
| [1] AVPR2 AVPR2 💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [1] 67 67 💬
|
| 43 | Tolvaptan 30 mg Tablet | [1] Tolvaptan Tolvaptan (Tolvaptan) | [1] Tolvaptan
Tolvaptan
(Tolvaptan) 💬
| [1] AVPR2 AVPR2 💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [1] 67 67 💬
|
| 44 | Tolvaptan 30 mg tablets | [1] Tolvaptan Tolvaptan (Tolvaptan) | [1] Tolvaptan
Tolvaptan
(Tolvaptan) 💬
| [1] AVPR2 AVPR2 💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [1] 67 67 💬
|
| 45 | Tolvaptan 30mg | [1] Tolvaptan Tolvaptan (Tolvaptan) | [1] Tolvaptan
Tolvaptan
(Tolvaptan) 💬
| [1] AVPR2 AVPR2 💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [1] 67 67 💬
|
| 46 | TOLVAPTAN 45/15 | [1] Tolvaptan Tolvaptan (Tolvaptan) | [1] Tolvaptan
Tolvaptan
(Tolvaptan) 💬
| [1] AVPR2 AVPR2 💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [1] 67 67 💬
|
| 47 | Tolvaptan 50mg Granules | [1] Tolvaptan Tolvaptan (Tolvaptan) | [1] Tolvaptan
Tolvaptan
(Tolvaptan) 💬
| [1] AVPR2 AVPR2 💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [1] 67 67 💬
|
| 48 | TOLVAPTAN 60/30 | [1] Tolvaptan Tolvaptan (Tolvaptan) | [1] Tolvaptan
Tolvaptan
(Tolvaptan) 💬
| [1] AVPR2 AVPR2 💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [1] 67 67 💬
|
| 49 | Tolvaptan 7.5 mg Tablet | [1] Tolvaptan Tolvaptan (Tolvaptan) | [1] Tolvaptan
Tolvaptan
(Tolvaptan) 💬
| [1] AVPR2 AVPR2 💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [1] 67 67 💬
|
| 50 | Tolvaptan in euvolemic hyponatremia | [1] Tolvaptan Tolvaptan (Tolvaptan) | [1] Tolvaptan
Tolvaptan
(Tolvaptan) 💬
| [1] AVPR2 AVPR2 💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [1] 72 72 💬
|
| 51 | Tolvaptan IR | [1] Tolvaptan Tolvaptan (Tolvaptan) | [1] Tolvaptan
Tolvaptan
(Tolvaptan) 💬
| [1] AVPR2 AVPR2 💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [1] 67 67 💬
|
| 52 | Tolvaptan MR | [1] Tolvaptan Tolvaptan (Tolvaptan) | [1] Tolvaptan
Tolvaptan
(Tolvaptan) 💬
| [1] AVPR2 AVPR2 💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [1] 67 67 💬
|
| 53 | Tolvaptan Oral Tablet | [1] Tolvaptan Tolvaptan (Tolvaptan) | [1] Tolvaptan
Tolvaptan
(Tolvaptan) 💬
| [1] AVPR2 AVPR2 💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [1] 72 72 💬
|
| 54 | Tolvaptan Suspension | [1] Tolvaptan Tolvaptan (Tolvaptan) | [1] Tolvaptan
Tolvaptan
(Tolvaptan) 💬
| [1] AVPR2 AVPR2 💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [1] 67 67 💬
|
| 55 | Tolvaptan Tablets | [1] Tolvaptan Tolvaptan (Tolvaptan) | [1] Tolvaptan
Tolvaptan
(Tolvaptan) 💬
| [1] AVPR2 AVPR2 💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [1] 67 67 💬
|